Klaus Kaier1,2, Holger Reinecke3, Huseyin Naci4, Lutz Frankenstein5, Martin Bode6,7, Werner Vach8, Philip Hehn8, Andreas Zirlik6, Manfred Zehender6, Jochen Reinöhl6. 1. Center for Medical Biometry and Medical Informatics, Faculty of Medicine, University of Freiburg, Stefan-Meier-Str. 26, 79104, Freiburg, Germany. kaier@imbi.uni-freiburg.de. 2. Department of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany. kaier@imbi.uni-freiburg.de. 3. Division of Vascular Medicine, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany. 4. LSE Health, Department of Social Policy, London School of Economics and Political Science, London, UK. 5. Department of Cardiology, Angiology, Pulmonology, University of Heidelberg, Heidelberg, Germany. 6. Department of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany. 7. Faculty of Business Management and Social Sciences, Osnabrück University of Applied Sciences, Osnabrück, Germany. 8. Center for Medical Biometry and Medical Informatics, Faculty of Medicine, University of Freiburg, Stefan-Meier-Str. 26, 79104, Freiburg, Germany.
Abstract
BACKGROUND: The impact of various post-procedural complications after transcatheter aortic valve implantation (TAVI) on resource use and their consequences in the German reimbursement system has still not been properly quantified. METHODS: In a retrospective observational study, we use data from the German DRG statistic on patient characteristics and in-hospital outcomes of all isolated TAVI procedures in 2013 (N = 9147). The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation was analyzed using both unadjusted and risk-adjusted linear and logistic regression analyses. RESULTS: A total of 235 (2.57%) strokes, 583 (6.37%) bleeding events, 474 (5.18%) cases of acute kidney injury and 1428 (15.61%) pacemaker implantations were documented. The predicted reimbursement of an uncomplicated TAVI procedure was €33,272, and bleeding events were associated with highest additional reimbursement (€12,839, p < 0.001), extra length of stay (14.58 days, p < 0.001), and increased likelihood of mechanical ventilation for more than 48 h (OR 17.91, p < 0.001). A more moderate complication-related impact on resource use and reimbursement was found for acute kidney injury (additional reimbursement: €5963, p < 0.001; extra length of stay: 7.92 days, p < 0.001; ventilation >48 h: OR 6.93, p < 0.001) as well as for stroke (additional reimbursement: €4125, p < 0.001; extra length of stay: 4.68 days, p < 0.001; ventilation >48 h: OR 5.73, p < 0.001). Pacemaker implantations, in contrast, were associated with comparably small increases in reimbursement (€662, p = 0.006) and length of stay (3.54 days, p = 0.006) and no impaired likelihood of mechanical ventilation more than 48 h (OR 1.22, p = 0.156). Interestingly, these complication-related consequences remain mostly unchanged after baseline risk-adjustment. CONCLUSIONS: Post procedural complications such as bleeding events, acute kidney injuries and strokes are associated with increased resource use and substantial amounts of additional reimbursement in Germany, which has important implications for decision making outside of the usual clinical sphere.
BACKGROUND: The impact of various post-procedural complications after transcatheter aortic valve implantation (TAVI) on resource use and their consequences in the German reimbursement system has still not been properly quantified. METHODS: In a retrospective observational study, we use data from the German DRG statistic on patient characteristics and in-hospital outcomes of all isolated TAVI procedures in 2013 (N = 9147). The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation was analyzed using both unadjusted and risk-adjusted linear and logistic regression analyses. RESULTS: A total of 235 (2.57%) strokes, 583 (6.37%) bleeding events, 474 (5.18%) cases of acute kidney injury and 1428 (15.61%) pacemaker implantations were documented. The predicted reimbursement of an uncomplicated TAVI procedure was €33,272, and bleeding events were associated with highest additional reimbursement (€12,839, p < 0.001), extra length of stay (14.58 days, p < 0.001), and increased likelihood of mechanical ventilation for more than 48 h (OR 17.91, p < 0.001). A more moderate complication-related impact on resource use and reimbursement was found for acute kidney injury (additional reimbursement: €5963, p < 0.001; extra length of stay: 7.92 days, p < 0.001; ventilation >48 h: OR 6.93, p < 0.001) as well as for stroke (additional reimbursement: €4125, p < 0.001; extra length of stay: 4.68 days, p < 0.001; ventilation >48 h: OR 5.73, p < 0.001). Pacemaker implantations, in contrast, were associated with comparably small increases in reimbursement (€662, p = 0.006) and length of stay (3.54 days, p = 0.006) and no impaired likelihood of mechanical ventilation more than 48 h (OR 1.22, p = 0.156). Interestingly, these complication-related consequences remain mostly unchanged after baseline risk-adjustment. CONCLUSIONS: Post procedural complications such as bleeding events, acute kidney injuries and strokes are associated with increased resource use and substantial amounts of additional reimbursement in Germany, which has important implications for decision making outside of the usual clinical sphere.
Authors: Matthew R Reynolds; Elizabeth A Magnuson; Kaijun Wang; Yang Lei; Katherine Vilain; Joshua Walczak; Susheel K Kodali; John M Lasala; William W O'Neill; Charles J Davidson; Craig R Smith; Martin B Leon; David J Cohen Journal: Circulation Date: 2012-02-03 Impact factor: 29.690
Authors: Anja Gutmann; Klaus Kaier; Stefan Sorg; Constantin von Zur Mühlen; Matthias Siepe; Martin Moser; Annette Geibel; Andreas Zirlik; Ingo Ahrens; Hardy Baumbach; Friedhelm Beyersdorf; Werner Vach; Manfred Zehender; Christoph Bode; Jochen Reinöhl Journal: Int J Cardiol Date: 2014-11-11 Impact factor: 4.164
Authors: A Pieter Kappetein; Stuart J Head; Philippe Généreux; Nicolo Piazza; Nicolas M van Mieghem; Eugene H Blackstone; Thomas G Brott; David J Cohen; Donald E Cutlip; Gerrit-Anne van Es; Rebecca T Hahn; Ajay J Kirtane; Mitchell W Krucoff; Susheel Kodali; Michael J Mack; Roxana Mehran; Josep Rodés-Cabau; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys; Martin B Leon Journal: J Am Coll Cardiol Date: 2012-10-09 Impact factor: 24.094
Authors: Jan-Peter Braun; Hanswerner Bause; Frank Bloos; Götz Geldner; Marc Kastrup; Ralf Kuhlen; Andreas Markewitz; Jörg Martin; Hendrik Mende; Michael Quintel; Klaus Steinmeier-Bauer; Christian Waydhas; Claudia Spies Journal: Ger Med Sci Date: 2010-10-08
Authors: Jochen Reinöhl; Anja Gutmann; Marc Kollum; Constantin von Zur Mühlen; Hardy Baumbach; Melanie Avlar; Martin Moser; Christoph Bode; Manfred Zehender Journal: J Thromb Thrombolysis Date: 2013-05 Impact factor: 2.300
Authors: Carolina Donà; Matthias Koschutnik; Christian Nitsche; Max-Paul Winter; Veronika Seidl; Jolanta Siller-Matula; Markus Mach; Martin Andreas; Philipp Bartko; Andreas Anselm Kammerlander; Georg Goliasch; Irene Lang; Christian Hengstenberg; Julia Mascherbauer Journal: J Pers Med Date: 2022-02-21